Abstract:Introduction Major depressive disorder (MDD) is a prevalent and disabling condition. Approximately 30-50% of patients do not respond to first-line medication or psychotherapy. Therefore, several studies have investigated the predictive potential of pretreatment severity rating or neuroimaging features to guide clinical approaches that can speed optimal treatment selection. Objectives To evaluate the performance of 1) severity ratings (scores of Hamilton Depression/Anxiety Scale, illness duration, and sleep quality, etc.) and demographic characteristic and 2) brain magnetic resonance imaging (MRI) features in predicting treatment outcomes for MDD. Second, to assess performance variations among varied modalities and interventions in MRI studies. Methods We searched studies in PubMed, Embase, Web of Science, and Science Direct databases before March 22, 2023. We extracted a confusion matrix for prediction in each study. Separate meta-analyses were performed for clinical and MRI studies. The logarithm of diagnostic odds ratio [log(DOR)], sensitivity, and specificity were conducted using Reitsma's random effect model. The area under curve (AUC) of summary receiver operating characteristic (SROC) curve was calculated. Subgroup analyses were conducted in MRI studies based on modalities: resting-state functional MRI (rsfMRI), task-based fMRI (tbfMRI), and structural MRI (sMRI), and interventions: antidepressant (including selective serotonin reuptake inhibitors [SSRI]) and electroconvulsive therapy (ECT). Meta-regression was conducted 1) between clinical and MRI studies and 2) among modality or intervention subgroups in MRI studies. Results We included ten studies used clinical features covering 6494 patients, yielded a log(DOR) of 1.42, AUC of 0.71, sensitivity of 0.61, and specificity of 0.74. In terms of MRI, 44 studies with 2623 patients were included, revealing an overall log(DOR) of 2.53. The AUC, sensitivity, and specificity were 0.89, 0.78, and 0.75. Studies using MRI features had a higher sensitivity (0.89 vs. 0.61) in predicting treatment outcomes than clinical features (P < 0.001). RsfMRI had higher specificity (0.79 vs. 0.69) than tbfMRI subgroup (P = 0.01). No significant differences were found between sMRI and other modalities, nor between antidepressants (SSRIs and others) and ECT. Antidepressant studies primarily identified predictive imaging features in limbic and default mode networks, while ECT mainly focused on limbic network. Conclusions Our findings suggest a robust promise for pretreatment brain MRI features in predicting treatment outcomes in MDD, offering higher accuracy than clinical studies. While tasks in tbfMRI studies differed, those studies overall had less predictive utility than rsfMRI data. For MRI studies, overlapping but distinct network level measures predicted outcomes for antidepressants and ECT. Disclosure of Interest None Declared

A systematic review on the potential use of machine learning to classify major depressive disorder from healthy controls using resting state fMRI measures

The diagnostic performance of machine learning based on resting-state functional magnetic resonance imaging data for major depressive disorders: a systematic review and meta-analysis

Machine learning in major depression: From classification to treatment outcome prediction

Intelligent classification of major depressive disorder using rs-fMRI of the posterior cingulate cortex

Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features

Multivariate Machine Learning Analyses in Identification of Major Depressive Disorder Using Resting-State Functional Connectivity: A Multicentral Study

The alterations of brain functional connectivity networks in major depressive disorder detected by machine learning through multisite rs-fMRI data

EEG based Functional Connectivity in Resting and Emotional States may identify Major Depressive Disorder using Machine Learning

Resting-State Functional Magnetic Resonance Image to Analyze Electrical Biological Characteristics of Major Depressive Disorder Patients with Suicide Ideation

Unsupervised classification of major depression using functional connectivity MRI

An insight into diagnosis of depression using machine learning techniques: a systematic review

Classification of Major Depressive Disorder Based on Integrated Temporal and Spatial Functional MRI Variability Features of Dynamic Brain Network

Classifying Major Depression Patients and Healthy Controls Using EEG, Eye Tracking and Galvanic Skin Response Data

Revealing patterns in major depressive disorder with machine learning and networks

Classification of Depressive Disorder Based on RS-fMRI Using Multivariate Pattern Analysis with Multiple Features

Advancing Early Detection of Major Depressive Disorder: A Comparative Analysis of AI Models Using Multi-Site Functional MRI Data

Performances of Whole-Brain Dynamic and Static Functional Connectivity Fingerprinting in Machine Learning-Based Classification of Major Depressive Disorder

Quantitative Identification of Major Depression Based on Resting-State Dynamic Functional Connectivity: A Machine Learning Approach.

Brain magnetic resonance imaging outperforms clinical severity ratings in the prediction of treatment outcomes in major depressive disorder

A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder

Distinguishing between bipolar depression and unipolar depression based on the reward circuit activities and clinical characteristics: A machine learning analysis